Ustekinumab Demonstrates Lower Uveitis Risk in Moderate to Severe Psoriasis Patients Compared with Tumor Necrosis Factor-α Inhibitors

Chul Hwan Bang; Hyun Ju Oh; Yeong Ho Kim; Jin Hyung Jung; Ji Hyun Lee; Young Min Park; Ju Hee Han

doi:10.2340/actadv.v104.34206

Ustekinumab Demonstrates Lower Uveitis Risk in Moderate to Severe Psoriasis Patients Compared with Tumor Necrosis Factor-α Inhibitors

Chul Hwan Bang
, Hyun Ju Oh
, Yeong Ho Kim
, Jin Hyung Jung
, Ji Hyun Lee
, Young Min Park
, Ju Hee Han

Department of Dermatology

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Original language	English
Article number	adv34206
Journal	Acta Dermato-Venereologica
Volume	104
DOIs	https://doi.org/10.2340/actadv.v104.34206
State	Published - 2024

Access to Document

10.2340/actadv.v104.34206

Cite this

@article{1838cd77f9b74f9c9c417f8ef9753c89,

title = "Ustekinumab Demonstrates Lower Uveitis Risk in Moderate to Severe Psoriasis Patients Compared with Tumor Necrosis Factor-α Inhibitors",

author = "Bang, \{Chul Hwan\} and Oh, \{Hyun Ju\} and Kim, \{Yeong Ho\} and Jung, \{Jin Hyung\} and Lee, \{Ji Hyun\} and Park, \{Young Min\} and Han, \{Ju Hee\}",

year = "2024",

doi = "10.2340/actadv.v104.34206",

language = "English",

volume = "104",

journal = "Acta Dermato-Venereologica",

issn = "0001-5555",

publisher = "Medical Journals Sweden AB",

}

TY - JOUR

T1 - Ustekinumab Demonstrates Lower Uveitis Risk in Moderate to Severe Psoriasis Patients Compared with Tumor Necrosis Factor-α Inhibitors

AU - Bang, Chul Hwan

AU - Oh, Hyun Ju

AU - Kim, Yeong Ho

AU - Jung, Jin Hyung

AU - Lee, Ji Hyun

AU - Park, Young Min

AU - Han, Ju Hee

PY - 2024

Y1 - 2024

UR - https://www.scopus.com/pages/publications/85203749010

U2 - 10.2340/actadv.v104.34206

DO - 10.2340/actadv.v104.34206

M3 - Article

C2 - 39248291

AN - SCOPUS:85203749010

SN - 0001-5555

VL - 104

JO - Acta Dermato-Venereologica

JF - Acta Dermato-Venereologica

M1 - adv34206

ER -

Ustekinumab Demonstrates Lower Uveitis Risk in Moderate to Severe Psoriasis Patients Compared with Tumor Necrosis Factor-α Inhibitors

Access to Document

Other files and links

Researchers at Catholic University of Korea Report New Data on Uveitis (Ustekinumab Demonstrates Lower Uveitis Risk In Moderate To Severe Psoriasis Patients Compared With Tumor Necrosis Factor-a Inhibitors)

Cite this

Ustekinumab Demonstrates Lower Uveitis Risk in Moderate to Severe Psoriasis Patients Compared with Tumor Necrosis Factor-α Inhibitors

Access to Document

Other files and links

Press/Media

Researchers at Catholic University of Korea Report New Data on Uveitis (Ustekinumab Demonstrates Lower Uveitis Risk In Moderate To Severe Psoriasis Patients Compared With Tumor Necrosis Factor-a Inhibitors)

Cite this